Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Better than Symptom Analysis in Diagnosing Ovarian Cancer

By MedImaging International staff writers
Posted on 31 Jul 2009
Investigators recently compared symptom analysis to ultrasound in predicting ovarian cancer. They selected 272 women participating in yearly transvaginal screening (TVS) from 31,748 women enrolled in a free screening project, comparing symptom results to ultrasound and surgical pathology findings.

The investigators, from the University of Kentucky Chandler Medical Center-Markey Cancer Center (Lexington, USA), discovered that TVS performed better than symptoms analysis for detecting malignancies (73.3% vs. 20% sensitivity). While symptoms analysis performed better for distinguishing benign tumors (91.3% versus 74.4% specificity), adding symptom analysis to TVS actually resulted in poorer identification of malignancy (sensitivity = 16.7%), even as it improved the ability to distinguish benign tumors (specificity = 97.9%).

The researchers, who published their findings online July 13, 2009 (print issue date: August 15, 2009) in the journal Cancer, reported that the data indicate that while symptoms do identify ovarian malignancies, they are not as accurate as TVS. They added that informative symptoms could be expected to be absent in 80% of ovarian malignancies.

Related Links:
University of Kentucky Chandler Medical Center-Markey Cancer Center

Digital Radiography System (Ceiling Free)
Digix CF Series
Ultrasound Table
Women’s Ultrasound EA Table
Breast Localization System
MAMMOREP LOOP
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.